High Growth Tech Stocks in the United Kingdom
The United Kingdom's market has recently been influenced by weak trade data from China, causing the FTSE 100 to close lower as commodity-dependent companies felt the impact of reduced demand. In this context, identifying high-growth tech stocks involves looking for companies that can navigate global economic challenges and exhibit resilience through innovation and adaptability.
Top 10 High Growth Tech Companies In The United Kingdom
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
STV Group | 13.15% | 46.78% | ★★★★★☆ |
Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
Altitude Group | 23.46% | 27.56% | ★★★★★☆ |
YouGov | 14.29% | 29.79% | ★★★★★☆ |
Facilities by ADF | 52.00% | 144.70% | ★★★★★☆ |
Redcentric | 4.89% | 63.79% | ★★★★★☆ |
Windar Photonics | 63.60% | 126.92% | ★★★★★☆ |
Oxford Biomedica | 21.00% | 98.44% | ★★★★★☆ |
Beeks Financial Cloud Group | 22.12% | 36.94% | ★★★★★☆ |
Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 47 stocks from our UK High Growth Tech and AI Stocks screener.
Let's uncover some gems from our specialized screener.
Genus
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Genus plc is an animal genetics company with operations across North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia and has a market capitalization of approximately £1.41 billion.
Operations: Genus plc generates revenue primarily through its Genus ABS and Genus PIC segments, with contributions of £314.90 million and £352.50 million, respectively. The company is focused on animal genetics across various global regions including North America, Latin America, the UK, Europe, the Middle East, Russia, Africa, and Asia.
Despite a challenging year where Genus plc saw its earnings decline by 76.3%, contrasting sharply with the Biotech industry's average drop of 13.8%, there are signs of potential recovery. The company's R&D investments, integral to its strategic positioning, remain robust, aligning with an anticipated earnings growth of 37.4% per year, outpacing the UK market forecast of 14.1%. This growth is underpinned by a modest revenue increase projection of 3.7% annually, slightly ahead of the broader UK market's 3.6%. Moreover, recent affirmations of consistent dividend payouts underscore a commitment to shareholder returns despite current financial volatilities. Financially, Genus faced significant headwinds this past fiscal year as evidenced in their latest earnings report: sales dipped from GBP 689.7 million to GBP 668.8 million and net income plummeted from GBP 33.3 million to just GBP 7.9 million due largely to a one-off loss of £47.4M that skewed yearly comparisons. Yet, looking forward, the firm is poised for substantial profit recovery driven by strategic R&D expenditures which have historically catalyzed innovation and sustained long-term growth in high-tech sectors like biotechnology.
Delve into the full analysis health report here for a deeper understanding of Genus.
Examine Genus' past performance report to understand how it has performed in the past.
Informa
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Informa plc is an international company specializing in events, digital services, and academic research across various regions including the United Kingdom, Continental Europe, the United States, and China with a market capitalization of £10.78 billion.
Operations: Informa generates revenue through four main segments: Informa Tech (£426.70 million), Informa Connect (£630.20 million), Informa Markets (£1.67 billion), and Taylor & Francis (£636.70 million). The company is involved in events, digital services, and academic research across multiple regions including the UK, Europe, the US, and China.
Informa's strategic focus on expanding its high-growth tech and luxury event segments, evidenced by a 6.8% annual revenue growth forecast, is complemented by robust R&D investments that fuel innovation across its diversified business portfolio. The company's recent acquisition moves and partnerships, like the extended collaboration with Monaco, underscore its commitment to enhancing global reach and sector-specific expertise. Despite facing a substantial one-off loss of £213.5 million last year which impacted earnings negatively by 11.3%, Informa is poised for recovery with expected earnings growth of 21.6% annually, outstripping the UK market prediction of 14.1%. This forward-looking strategy is supported by a proactive share repurchase program where Informa bought back shares worth £338.9 million in the first half of 2024 alone, signaling confidence in its future trajectory within the competitive landscape of tech-driven B2B events.
Take a closer look at Informa's potential here in our health report.
Gain insights into Informa's historical performance by reviewing our past performance report.
Spirent Communications
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Spirent Communications plc is a company that offers automated test and assurance solutions across various regions including the Americas, Asia Pacific, Europe, the Middle East, and Africa, with a market capitalization of £1.01 billion.
Operations: Spirent Communications focuses on providing automated test and assurance solutions, with its primary revenue stream coming from the Networks & Security segment, generating $258.50 million.
Spirent Communications, navigating a challenging landscape with a 5.1% revenue growth forecast, is outpacing the UK market's 3.6% expectation. Despite recent setbacks including a significant one-off loss of $18M impacting financials, the firm is poised for robust recovery with earnings projected to surge by 40.5% annually. This optimism is bolstered by Spirent's strategic R&D allocation which stands at an impressive £30 million this year alone, underscoring its commitment to innovation in communications technology—particularly in emerging sectors like 5G Fixed Wireless Access and Wi-Fi testing solutions.
Next Steps
Discover the full array of 47 UK High Growth Tech and AI Stocks right here.
Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Interested In Other Possibilities?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include LSE:GNS LSE:INF and LSE:SPT.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]